Lipum

Founded: 2010

Products: A therapeutic antibody directed towards BSSL - a novel target for treatment of autoimmune chronic inflammatory diseases.

Market: They aim to eliminate or alleviate painful symptoms and improve the quality of life for millions of patients suffering.